Delivery Order SPE2DB20D3101-SPE2DB24FRMH5
Award Date 6/10/24
Potential Completion Date 6/11/24
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Exforge 5-320 mg tablets. The $2,856.80 firm-fixed-price contract has an ultimate completion date of August 8, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of...
- The Defense Logistics Agency (DLA) awarded a $1,076.29 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide EXFORGE HCT 10-160-12.5 MG TAB 30S. This is a component of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Exforge 5-160 mg tablets. The contract has a ceiling value of $4,172.08 and a completion date of January 23, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EXFORGE 10-160 MG TABLET 30S. The firm fixed price contract has a ceiling value of $1,200.60 and an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,401.85 delivery order contract is for the delivery of Exforge 10-320 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of August 30, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of a prescription medication, Exforge 10-160 mg tablet, at a total ceiling value of $10,772.48. The contract has an ultimate completion date of April 17, 2024. Amerisourcebergen, through its Corporate Office Division, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $6,862.00, is to provide pharmaceutical products including the medication Exforge HCT 5-160-12.5 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,023.95, is for the supply of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through January 22, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The award is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $3,365.33 and a performance period ending on April 7, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,145.66 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement. The place of performance is listed as Conshohocken, Pennsylvania, which coincides with AmerisourceBergen's...